UroGen Pharma (URGN) Enterprise Value Growth (3y) (2019 - 2026)
UroGen Pharma (URGN) Enterprise Value Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | UroGen Pharma | 2.13 Bn | 1.99 Bn | 46.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.19% |
| Dec 31, 2025 | -6.41% |
| Sep 30, 2025 | -9.82% |
| Jun 30, 2025 | -26.52% |
| Mar 31, 2025 | -12.81% |
| Dec 31, 2024 | -38.47% |
| Sep 30, 2024 | -32.95% |
| Jun 30, 2024 | -25.82% |
| Mar 31, 2024 | -29.29% |
| Dec 31, 2023 | -10.32% |
| Sep 30, 2023 | -7.21% |
| Jun 30, 2023 | 27.69% |
| Mar 31, 2023 | 18.25% |
| Dec 31, 2022 | 12.08% |
| Sep 30, 2022 | 15.36% |
| Jun 30, 2022 | 25.73% |
| Mar 31, 2022 | 17.96% |
| Dec 31, 2021 | 4.26% |
| Sep 30, 2021 | 1.07% |
| Jun 30, 2021 | -0.48% |